The GalliaPharm 68Ge/ 68Ga generator - Eckert & Ziegler bets on long-term radiopharmacy demand
02.07.2026 - 18:09:54 | ad-hoc-news.de
By Daniel Foster, ad hoc news Software & Services Desk. Reviewed July 02, 2026, 12:15 PM ET. Details in the imprint.
GalliaPharm 68Ge/68Ga generator sits behind a lead-glass shield, its compact metal body humming quietly as a technician prints the next patient label. The generator, supplied by Eckert & Ziegler, is one of the hidden workhorses that keep PET/CT schedules running on time in nuclear medicine departments.
Long-lived source for Ga-68
GalliaPharm is a 68Ge/68Ga generator system that provides a reliable source of gallium-68 for the preparation of PET radiopharmaceuticals, including Ga-68 labeled tracers used in oncology and cardiology.
The generator uses germanium-68, a long-lived parent radionuclide with a half-life of about 271 days, which allows a single unit to serve a clinic for many months, depending on activity and elution schedule.
Role in PET imaging workflows
In practice, technologists like Dr. Jana Müller at a mid-size German hospital rely on GalliaPharm to produce Ga-68 eluates that are then combined with specific precursors on automated synthesis modules, enabling same-day production of PET tracers like Ga-68 PSMA or Ga-68 DOTATATE for diagnostic imaging.
For US radiopharmacies, gallium-68 generators such as GalliaPharm are typically used under strict regulatory frameworks and in conjunction with FDA-approved or investigational tracers, making generator reliability and shelf life critical for business planning and patient service.
More on Eckert & Ziegler's nuclear medicine portfolio
For US retail investors and professionals tracking radiopharmacy demand, Eckert & Ziegler’s product mix in isotope supply and generators is a key revenue driver.
Generator design and handling
According to Eckert & Ziegler’s product documentation, GalliaPharm is supplied as a shielded generator unit with an integrated column on which the 68Ge is immobilized; gallium-68 is eluted with hydrochloric acid solution to yield Ga-68 chloride suitable for further synthesis steps.
The generator is designed for routine use in hospital radiopharmacies and industrial manufacturing sites, with standardized connections and protocols that dovetail with commonly used synthesis modules, reducing setup time and training overhead.
Regulatory and market context
While GalliaPharm itself is part of the radioisotope supply chain rather than a finished drug, its availability and performance help support a growing global market for Ga-68 based PET imaging agents, especially in prostate cancer and neuroendocrine tumor diagnostics.
Analysts covering radiopharmacy and nuclear medicine equipment have pointed to increased demand for Ga-68 generators as imaging centers expand PET capacity beyond fluorodeoxyglucose (FDG) to more specialized tracers, a trend that aligns with Eckert & Ziegler’s focus on isotope supply solutions.
Company context and stock
Eckert & Ziegler, headquartered in Berlin, positions GalliaPharm as part of its larger isotopes and radiopharmaceutical components business, which includes generators, sealed sources, and services for nuclear medicine and industry.
Shares of Eckert & Ziegler (Xetra: EZ7, ISIN DE0005659700) trade in euros in Frankfurt, with the company emphasizing its isotope supply and radiopharmacy portfolio as long-term demand drivers rather than short-term cycles in any single generator line.
Key facts on GalliaPharm
- Product: GalliaPharm 68Ge/68Ga generator
- Manufacturer: Eckert & Ziegler AG
- Category: Software & Services (radiopharmacy support)
- Launch: Marketed in the 2010s for clinical and research use
- MSRP / Price: Pricing typically negotiated individually with radiopharmacies; not publicly listed
- Availability: Available to nuclear medicine centers and radiopharmacies in Europe and other regions subject to local regulation
- Target audience: Hospital radiopharmacies, PET centers, radiopharmaceutical manufacturers
- Standout / USP: Long-lived Ge-68 parent enabling extended Ga-68 generator usage for PET tracer production
This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.
